Jørgen Bjerggaard Jensen
Clinical trials sponsored by Jørgen Bjerggaard Jensen, explained in plain language.
-
Bladder cancer breakthrough? study tests chemo to avoid surgery
Disease control CompletedThis study tested whether intensive chemotherapy delivered directly to the bladder could control recurrent bladder cancer and potentially avoid surgery for some patients. It compared this intensive chemo approach against the standard treatment of surgery followed by chemo in 120 …
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New bladder cancer surgery technique aims to reduce tumor recurrence
Disease control CompletedThis study compared two surgical methods for removing early-stage bladder tumors that haven't spread into the muscle wall. Researchers tested whether removing the entire tumor in one piece (En Bloc) leads to better diagnosis and fewer cancer returns compared to the standard metho…
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Urine test could speed up bladder cancer diagnosis in remote communities
Diagnosis CompletedThis study tested whether a simple urine test could help doctors decide which patients in Greenland need a more invasive bladder exam (cystoscopy) to check for cancer. The goal was to create a faster, more efficient screening process, especially for areas with limited access to s…
Sponsor: Jørgen Bjerggaard Jensen • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
New scan could help bladder cancer patients keep their bladder
Diagnosis CompletedThis study tested a special imaging scan (15O-H2O PET/MR) to see if it could accurately tell which patients with muscle-invasive bladder cancer had their tumor completely eliminated by chemotherapy before surgery. The goal was to identify patients who might safely avoid having th…
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC